Literature DB >> 10954542

Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection.

L H Thomas1, M I Wickremasinghe, M Sharland, J S Friedland.   

Abstract

Respiratory syncytial virus (RSV) infection is the major cause of severe bronchiolitis in infants. Pathology of this infection is partly due to excessive proinflammatory leukocyte influx mediated by chemokines. Although direct infection of the respiratory epithelium by RSV may induce chemokine secretion, little is known about the role of cytokine networks. We investigated the effects of conditioned medium (CM) from RSV-infected monocytes (RSV-CM) on respiratory epithelial (A549) cell chemokine release. RSV-CM, but not control CM (both at a 1:5 dilution), stimulated interleukin-8 (IL-8) secretion from A549 cells within 2 h, and secretion increased over 72 h to 11,360 +/- 1,090 pg/ml without affecting cell viability. In contrast, RSV-CM had only a small effect on RANTES secretion. RSV-CM interacted with direct RSV infection to synergistically amplify IL-8 secretion from respiratory epithelial cells (levels of secretion at 48 h were as follows: RSV-CM alone, 8,140 +/- 2,160 pg/ml; RSV alone, 12,170 +/- 300 pg/ml; RSV-CM plus RSV, 27,040 +/- 5,260 pg/ml; P < 0.05). RSV-CM induced degradation of IkappaBalpha within 5 min but did not affect IkappaBbeta. RSV-CM activated transient nuclear binding of NF-kappaB within 1 h, while activation of NF-IL6 was delayed until 8 h and was still detectable at 24 h. Promoter-reporter analysis demonstrated that NF-kappaB binding was essential and that NF-IL6 was important for IL-8 promoter activity in RSV-CM-activated cells. Blocking experiments revealed that the effects of RSV-CM depended on monocyte-derived IL-1 but that tumor necrosis factor alpha was not involved in this network. In summary, RSV infection of monocytes results in and amplifies direct RSV-mediated IL-8 secretion from respiratory epithelial cells by an NF-kappaB-dependent, NF-IL6-requiring mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954542      PMCID: PMC116353          DOI: 10.1128/jvi.74.18.8425-8433.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Fibroblast interleukin 1 beta: synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation.

Authors:  J A Elias; M M Reynolds; R M Kotloff; J A Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

Review 2.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

3.  Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung.

Authors:  T J Standiford; S L Kunkel; M A Basha; S W Chensue; J P Lynch; G B Toews; J Westwick; R M Strieter
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

4.  Demonstration of respiratory syncytial virus in an autopsy series.

Authors:  K A Neilson; E J Yunis
Journal:  Pediatr Pathol       Date:  1990

5.  Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES.

Authors:  T J Schall; K Bacon; K J Toy; D V Goeddel
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

6.  Productive infection of isolated human alveolar macrophages by respiratory syncytial virus.

Authors:  J R Panuska; N M Cirino; F Midulla; J E Despot; E R McFadden; Y T Huang
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

7.  Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.

Authors:  S Becker; J Quay; J Soukup
Journal:  J Immunol       Date:  1991-12-15       Impact factor: 5.422

8.  Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6.

Authors:  S Becker; H S Koren; D C Henke
Journal:  Am J Respir Cell Mol Biol       Date:  1993-01       Impact factor: 6.914

9.  Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8.

Authors:  F Bazzoni; M A Cassatella; F Rossi; M Ceska; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes.

Authors:  A Rot; M Krieger; T Brunner; S C Bischoff; T J Schall; C A Dahinden
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  9 in total

1.  Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages.

Authors:  Helen M Marriott; Kate A Gascoyne; Ravi Gowda; Ian Geary; Martin J H Nicklin; Francesco Iannelli; Gianni Pozzi; Timothy J Mitchell; Moira K B Whyte; Ian Sabroe; David H Dockrell
Journal:  Infect Immun       Date:  2011-12-12       Impact factor: 3.441

2.  Effects of paramyxoviral infection on airway epithelial cell Foxj1 expression, ciliogenesis, and mucociliary function.

Authors:  D C Look; M J Walter; M R Williamson; L Pang; Y You; J N Sreshta; J E Johnson; D S Zander; S L Brody
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  Modulation of respiratory syncytial virus-induced prostaglandin E2 production by n-3 long-chain polyunsaturated fatty acids in human respiratory epithelium.

Authors:  Dani-Louise Bryan; Prue Hart; Kevin Forsyth; Robert Gibson
Journal:  Lipids       Date:  2005-10       Impact factor: 1.880

4.  Reduced clearance of respiratory syncytial virus infection in a preterm lamb model.

Authors:  David K Meyerholz; Branka Grubor; Sasha J Fach; Randy E Sacco; Howard D Lehmkuhl; Jack M Gallup; Mark R Ackermann
Journal:  Microbes Infect       Date:  2004-11       Impact factor: 2.700

5.  Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses.

Authors:  Richard Singleton; Nathalie Etchart; Sam Hou; Lisa Hyland
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

6.  Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line.

Authors:  Yuh-Chin T Huang; Zhuowei Li; Xhevahire Hyseni; Michael Schmitt; Robert B Devlin; Edward D Karoly; Joleen M Soukup
Journal:  Genomic Med       Date:  2009-05-15

7.  Analysis of global gene expression changes in human bronchial epithelial cells exposed to spores of the allergenic fungus, Alternaria alternata.

Authors:  M C Babiceanu; B A Howard; A C Rumore; H Kita; C B Lawrence
Journal:  Front Microbiol       Date:  2013-07-19       Impact factor: 5.640

8.  Actin- and clathrin-dependent mechanisms regulate interferon gamma release after stimulation of human immune cells with respiratory syncytial virus.

Authors:  Jop Jans; Hicham elMoussaoui; Ronald de Groot; Marien I de Jonge; Gerben Ferwerda
Journal:  Virol J       Date:  2016-03-22       Impact factor: 4.099

9.  Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells.

Authors:  Andrea Tuettenberg; Stephan Koelsch; Jürgen Knop; Helmut Jonuleit
Journal:  Exp Dermatol       Date:  2007-03       Impact factor: 3.960

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.